1. Prevalence and concordance of human papillomavirus infection at multiple anatomic sites among HIV-infected women from Chennai, India.
- Author
-
Menezes LJ, Poongulali S, Tommasino M, Lin HY, Kumarasamy N, Fisher KJ, Saravanan S, Gheit T, Ezhilarasi C, Jeeva A, Lu B, and Giuliano AR
- Subjects
- Adult, Anal Canal virology, Cervix Uteri virology, DNA, Viral genetics, Female, HIV Infections epidemiology, HIV Infections virology, Humans, India, Middle Aged, Multiplex Polymerase Chain Reaction, Oropharynx virology, Papillomaviridae isolation & purification, Papillomavirus Infections complications, Papillomavirus Infections epidemiology, Papillomavirus Infections pathology, Papillomavirus Infections virology, Prevalence, Prospective Studies, Sexual Behavior, Socioeconomic Factors, Surveys and Questionnaires, Anal Canal pathology, Cervix Uteri pathology, HIV Infections complications, Oropharynx pathology, Papillomaviridae genetics
- Abstract
Human papillomavirus (HPV) infection at the cervix, anus and oropharynx has been rarely concurrently estimated among HIV-infected women. Using multiplex polymerase chain reaction testing, we prospectively evaluated HPV genotype distribution across three anatomic sites among 50 eligible HIV-infected women from Chennai, India, who provided biological specimens and answered a sexual behaviour questionnaire. We also assessed clinical and behavioural factors related to HPV prevalence. Oncogenic HPV prevalence was comparable between the anus and cervix at 52.2% and 52.0% and lower at the oropharynx at 13.2%; 78% of women with a cervical HPV infection had the same type in the anus. Newly acquired oncogenic HPV infections were lower at cervix (24%) than anus (35%) at three months. 'Any type' cervical HPV prevalence was higher among women with low education and less than five years since HIV diagnosis. CD4+ count and antiretroviral therapy status were not associated with HPV prevalence at the three anatomic sites; however, enrolment cervical HPV16 prevalence was elevated among women with nadir CD4+ <200 cells/µL and enrolment CD4+ <350 cells/µL. Regular cervical screening is essential in HIV-infected Indian women irrespective of CD4+ count and antiretroviral therapy status. Additional research clarifying the natural history of anal HPV infection is also needed in this population., (© The Author(s) 2015.)
- Published
- 2016
- Full Text
- View/download PDF